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Abstract: 
Introduction: Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycaemia with 
disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, 
insulin action, or both.
(1)
 
Objectives This study aimed to estimate the levels of total cholesterol and triglycerides as control  
markers of type 2 diabetes mellitus in Sudanese patients.  
Methods: Seventy Sudanese controlled NIDDM patients of age 42-80 years and of diabetes duration 1-27 
years, 30  non diabetic subjects age and sex-matched taken as a control group. Fasting blood glucose, 
total cholesterol, and triglycerides (TG) were measured and the results obtained were statistically 
analysed. 
Results: There were no statistically significant differences between diabetic group and control group 
observed in TG levels.  The total cholesterol in the diabetic group showed significant increase than the 
control group (P=0.04), also this study showed, 64.3% of the diabetic group had FBG>140mg/dl , 24.3% 
had cholesterol level >240 mg/dl and 9% had Triglycerides level >200 mg/dl. 
Conclusion: This study suggests the need for improving glycemic control in Sudanese diabetic patients, 





 جفذْ  ِزْتصاسذنا  ػبعن ٕ٘ٛحًٕٛكنا ىٛٛقخنا واذخخصلا ٖٕخضي عي َّساقي ٍٛنٕضَلاا ٙهع ٍٚذًخعًنا شٛغ ٘شكضنا ٙظشي ذُع شكضنا
 ٙهع ّصاسذنا ِزْ جهًخشإ .شًعنأ عُٕنا شفَ ٍي ءاحصأ100  ىُٓي صخش70  حٔاشخح ٍٛنٕضَلاا ٙهع ٍٚذًخعًنا شٛغ ٘شكضناب اعٚشي
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 ٍٛب ىْساًعأ42-80  ٍٛب ىٓظشي ةشخف ذخًحٔ اياع1- 27   ٔ اياع30 . شًعنأ عُٕنا شفَ ٍي ءاحصأ  ثاصاٛقنا  ّصاسذنا ِزْ جًُعح
.اٛئاصحإ لاٛهحح جئاخُنا جههحٔ ىضجنا تهخك ششؤئ لٔشضٛهجنا مٛصأ ٙثلاث ، لٔشٛخضٛنٕكنا ،ىئاصنا ود شكص :ّٛحلأا ّٕٚٛحًٕٛكنا   
  دٕجٔ وذع تصاسذنا ثشٓظاي ٔر فلاخخإ ٙف ءاحصلأا تعًٕجئ ٘شكضنا ٙظشي تعًٕجي ٍٛب ُٙع ثإٚخضي لٔشضٛهجنا مٛصأ ٙثلاث
اًُٛب ذجٔ لٔشٛخضٛنٕكنا ٔ ىئاصنا ود شكص ٍي مك زٛكشح ٗهكنا  اعفحشي اعافحسإ٘شكضنا ٙظشي تعًٕجي ذُع ُٙعي ار . ٕ٘خضي
 لٔشٛخضٛنٕكنا شٓظاعي ابجٕي اغابحسإ  .لٔشضٛهجنا مٛصأ ٙثلاث  
 ىٛضقخن اقبغتٛعًج ظشيٗ تبضَ ٌأ ّصاسذنا ِزْ ثشٓظأ ّٛكٚشيلأا ًّٛناعنا ٘شكضنا 35.7  ةذٛج ػبظ تجسذب ٌٔزًٛخٚ ( شكص  ساٛق لذعي
 ٍي مقأ ىٓٚذن ىئاصنا ود140شخهي/جي)  اًُٛب75.7% ةذٛج ػبظ تجسذب ٌٔزًٛخٚ ( لٔشٛخضٛنٕكهن ٍي مقأ ىٓٚذن لٔشٛخضٛنٕكنا ٕ٘خضي 
240شخهي/جئ )91 تجسذب ٌٔزًٛخٚ %ةذٛج ػبظ نلٔشضٛهجنا مٛصأ ٙثلاث (ٕ٘خضي  ٍي مقأ ىٓٚذن لٔشضٛهجنا مٛصأ ٙثلاث 200شخهي/جي) . 
شبخعٚ ّٛهعٔ طعب ٌا    ٗظشًنا ءلاؤْ شٛغ.٘شكضنا ضشًن ِذٛج ػبظ تجسذب ٍٛعخًخي 
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Introduction: 
Diabetes mellitus (DM) is a syndrome characterized by disordered metabolism and abnormally high 
blood glucose (hyperglycaemia) resulting from insufficient levels of insulin
(2)
. Abnormal lipid profile is 
an important risk factor in the development of macro vascular atherosclerotic complications in patients 
with type 2 diabetes mellitus
(3)
. Chronic elevation of blood glucose level leads to damage of blood vessels 
(angiopathy). The endothelial cells lining the blood vessels take in more glucose than normal, since they 
don't depend on insulin. They then form more surface glycoprotein's than normal, and cause the basement 
membrane to grow thicker and weaker. In diabetes, the resulting problems are grouped under "micro 
vascular disease" (due to damage to small blood vessels) and "macro vascular disease" (due to damage to 
the arteries) 
(4)
. Using pig model for studying dyslipidaemia and atherosclerosis in diabetes. There are 
marked increases in total choleslerol, TG, glucose, in type 2 diabetic patients
(5)
. Type 2diabetes is a major 
risk factor of the development of atherosclerosis in humans. Several studies showed that increased levels 
of total cholesterol and triglycerides in Patients with type 2 DM 
(6,7)
. Patients with type 2 DM who are 
being treated on insulin had a better lipid profile (TC and TG) compared with those patients on oral 
hypoglycemic agents. Meanwhile, Lp (a) levels were raised in all diabetic patients and seem not to be 




This is a case control study. This study was conducted in a clinical center for diabetic patients (Abu Agla) 
in wad Medani – Gezira state about 180 Km south east of Khartoum. The study was carried out during the 
period March to May 2008. Seventy samples from Sudanese subjects with type 2 diabetes mellitus were 
randomly allocated in this study, with age range 42 – 80 years. Male to female ratio was 28/42. And thirty 
samples from non diabetic Sudanese subjects were collected to serve as age and sex- matched control 
group. All study subjects gave consent to the study. A questionnaire was designed to include personal 
history, clinical picture and laboratory investigations. Exclusion criteria included patients with IDDM, 
heart disease, and those patients taking hypolipideamic drugs. Blood samples were collected after an 
overnight fasting (12 hours) from both diabetic and non diabetic groups. Five ml of venous blood were 
collected and divided into two tubes. Two ml of blood were drawn into fluoride sterile containers and 
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plasma was separated by centrifugation at 4000 rpm for 10 minutes for estimation of fasting Blood 
glucose (FBG) .The rest 3 ml were collected in plane container separated, and the serum was used for 
estimation of Cholesterol and Triglycerides. All tests were done by enzymatic colorimetric method.  
Values were presented as mean ± standard deviation of all measured variables. Student t-test was applied 
to compare the measured parameters between patients and controls. A value of P<0.05 was considered 
statistically significant.   
Results: 
characteristics of study group: 
Age ranges in NIDDM group and the age matched non diabetic group was 42-80 years. Age (means ± 
standard deviation) for the study groups are presented in Table (1).  
BMI (means) in the NIDDM group and the age matched non diabetic group was 26.58 Kg/m2 and 22.08 
Kg/m2 respectively. BMI (mean ± SD) for the study group are presented in table (1). Mean BMI value in 
NIDDM group was significantly higher than mean BMI value of age matched non diabetic group 
(P<0.001). Family history of diabetes mellitus (FH) was classified as negative or positive family history. 
The ratio of No/Yes FH in non diabetic group was 25/5 while in the diabetic group 26/44 (Table 1). 
The ratio of male/female in diabetic group was 28/42 while in non diabetic group 13/17 is presented in 
Table (1). Family history of diabetes and sex in diabetic& non diabetic groups. In this study a high 
significant difference was observed in BMI between NIDDM & control subjects (P<0.001).   
Biochemical Parameters: 
FBG levels (mean ± SD) for both study groups are presented in Table (1). The NIDDM group had a 
higher level of FBG than the non diabetic group. The difference between the mean values was highly 
significant at (P<0.0001). Cholesterol levels (mean ± SD) for both study groups are presented in Table 
(1). The NIDDM group had significantly higher levels of cholesterol compared with non diabetic subjects 
(P<0.04). The levels (mean ± SD) of the TG for both study groups are also presented in Table (1) No 
significant differences were observed in the mean values of TG between the two study subjects. 
Table 1: Characteristics of the study groups  
 






0.007 54.10 ± 9.67 59.86 ± 9.57 Age (year) 
- - 52.64 ± 9.06 Age at onset of DM 
(years) 
- - 7.40  ± 6.47 Duration of DM (years) 
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- 16.6% 62.8% Family  history of DM 
0.0001 22.08  ± 4.60 26.58 ± 4.49 BMI (kg/m2)                      
<0.0001 88.87 ± 13.05 174.59 ± 61.94 FBG (mg/dl) 
0.04 158.95 ± 33.75 179.45 ±  49.7 Total cholesterol (mg/dl) 
0.94 115.79 ± 53.05 114.71 ± 81.98 TG (mg/dl) 
 
Assessment of Metabolic Control of NIDDM Patients: 
Degree of metabolic control in NIDDM patients using FBG level: 
Table (2) shows the distribution of NIDDM Group according To their FBG level. Metabolic control was 
assessed using mean FBG level, according to the national diabetes study group classification (10) and 
graded as:- 
I)   Excellent (great) control (FBG <115 mg/dl) 
II)  Acceptable (good) control (FBG <140 mg/dl) 
III) Poor (bad) control (FBG >140 mg/dl) 
18.6 % of diabetic patients were Excellent glycaemic controlled diabetics, 17.1 % of diabetics were good 
controlled diabetics, while 64.3% were poor controlled diabetics. 
Degree of metabolic control in NIDDM patients using cholesterol levels (TC): 
Table (2) shows the metabolic Assessment of NIDDM Patient Using Cholesterol levels. 
Metabolic control was assessed using mean TC level, according to the national diabetes study group 
classification (10) and it was graded as follows: 
I)   Excellent (great) control (cholesterol <200 mg/dl) 
II)  Acceptable (good) control (cholesterol 200-239 mg/dl) 
III) Poor (bad) control (cholesterol >240mg/dl) 
75.7% of study diabetic population was considered to be excellent, moderate controlled diabetics, while 
24.3 % were poorly controlled. 
Degree of metabolic control in NIDDM patients using triglycerides levels (TG): 
Table (2) shows the metabolic Assessment of NIDDM Patient Using Triglycerides levels. 
Metabolic control was assessed using mean TG level, according to the national diabetes study group 
classification (10) and it was graded as follows: 
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I)   Excellent (great) control (Triglycerides <150 mg/dl) 
II)  Acceptable (good) control (Triglycerides 150-200 mg/dl) 
III) Poor (bad) control (Triglycerides >200mg/dl) 
91% of study diabetic population was considered to be excellent, moderate controlled diabetics, while 10 
% were poorly controlled. 
Table 2: Classification of the diabetic patients according to the national diabetes study group 
classification:   
 
Assessment of the 
glycaemic control of the 
diabetic patients in 
relation to the normal 
range of non diabetic 
control group. 
Figure (1) shows the 
percentage of NIDDM 
patients with excellent 
glycaemic control in 
relation to the normal range 
of the non diabetic 
control group. The 
percentage of the total 
diabetic study group who 
were within the normal 
ranges of the non diabetic 
study group as follows: 
11% for FBG, 80% for 
cholesterol and 92% for 




Percentage No. of 
patients 





18.6% 13 <115 Excellent 
17.1% 12 <140 Acceptable 
64.3% 45 >140 Poor 
Percentage  No. of 
patients 





21 15 <200 Excellent 
54.7 38 200-239 Acceptable 
24.3 17 ≥240 Poor 
TG 
81 57 < 150 Excellent 
10 7 150 - 200 Acceptable 
9 6 >200 Poor 
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Distribution of diabetic patients according to the range of 
FBG, cholesterol, and TG in the control group 
Exceeding the range
With the range of control group
 
Figure 1: Distribution of diabetic patients according to the range of FBG, cholesterol, and TG in 
the control group  
 
Discussion: 
The mean value FBG in NIDDM group was higher than that of non diabetic group and the difference is 
statistically significant at P <0.001. The distribution of FBG among diabetic group was 18.6 % for 
<115mg/dl (excellent control), 17.1 % for <140mg/dl (acceptable control, and 64.3% for >140mg/dl 
(poor control).This result reveals that 35.7 of total diabetic group were in good glycaemic control
 (9)
 
reported that 140 mg/dl of FBG is the upper limit of acceptable glycaemic control. The mean value of 
cholesterol in the NIDDM study group was 179.45± 49.79 mg/dl which was higher than that of the 
corresponding non diabetic study group 158.95 ±33.75. The difference was statistically significant at the 
level of P <0.05. This finding is in line with the finding of Owen.
 (10)
 
The mean values of triacylglycerol were not statistically significantly different from the corresponding 
non diabetic study group. This is in line with findings of a previous study result were no significant 
difference noted in the levels of TG.
(6)
 Cholesterol correlated significantly positive with TG (r = 0.294, 
P<0.05).  
 
In summary it was found that poor control of diabetes mellitus that is reflected mainly by increase 
in fasting blood glucose (FBG) and total cholesterol (TC) in diabetic subjects as compared to age matched 
non diabetic control. 
We recommend that the measurement of lipid profiles in Sudanese diabetic patients can be used as 
a marker for glyceamic control.   
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